India to Canada: Allopurinol Export Trade Route
India has recorded 157 verified shipments of Allopurinol exported to Canada, representing a combined trade value of $7.7M USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $49.1K USD. The leading Indian exporter is IPCA LABORATORIES LIMITED , which accounts for 53% of total export value with 70 shipments worth $4.1M USD. On the buying side, NA is the largest importer in Canada with $3.5M USD in purchases. The top 3 suppliers — IPCA LABORATORIES LIMITED , IPCA LABORATORIES LIMITED, LINCOLN PHARMACEUTICALS LTD — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Canada Allopurinol corridor is one of India's established pharmaceutical export routes, with 157 shipments documented worth a combined $7.7M USD. The route is dominated by IPCA LABORATORIES LIMITED , which alone accounts for roughly 53% of all export value, reflecting the consolidated nature of India's allopurinol manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $49.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with allopurinol's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 29.6%, placing it at rank #20 among India's top allopurinol export destinations globally.
On the import side, key buyers of Indian allopurinol in Canada include NA, Marcan Pharmaceuticals Inc. , MARCAN PHARMACEUTICALS INC and 4 others. NA is the single largest importer with 58 shipments valued at $3.5M USD.
